This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Piotr S Kowalski
Introduction
Piotr S Kowalski is a notable inventor based in Cork, Ireland. He has made significant contributions to the field of molecular biology, particularly in the engineering of circular RNA for use in eukaryotic cells. His innovative work has the potential to advance our understanding of gene expression and therapeutic applications.
Latest Patents
Kowalski holds a patent for "Circular RNA for translation in eukaryotic cells." This patent discloses methods and constructs for engineering circular RNA, which includes a vector designed to produce circular RNA that is translatable or biologically active inside eukaryotic cells. The vector comprises several key elements, including homology arms, intron fragments, and coding regions, allowing for the effective production and purification of circular RNA. This invention represents a significant advancement in the field of genetic engineering.
Career Highlights
Kowalski is affiliated with the Massachusetts Institute of Technology, where he continues to engage in groundbreaking research. His work focuses on the development of innovative methods for RNA engineering, which could have far-reaching implications in biotechnology and medicine.
Collaborations
Throughout his career, Kowalski has collaborated with esteemed colleagues, including Daniel Griffith Anderson and Robert Alexander Wesselhoeft. These collaborations have fostered a rich environment for innovation and discovery in the field of molecular biology.
Conclusion
Piotr S Kowalski's contributions to the field of circular RNA engineering exemplify the spirit of innovation in modern science. His work not only enhances our understanding of genetic mechanisms but also paves the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
